A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.